Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0376219930300010083
Chonnam Medical Journal
1993 Volume.30 No. 1 p.83 ~ p.91
6-Ketoprostaglandin F_(12) and Thromboxane B©ü Concentrations of Maternal Blood in Pregnancy Induced Hypertension





Abstract
Pathogenesis of pregnancy-induced hypertension is still controversial. The purpose of this study is to investigate pathophysiologic correlation between prostanoid con¡þcentration in maternal blood and pregnancy-induced hypertension. This study was performed on 47 pregnant patients associated with pregnancy-induced hypertension and 17 normal pregnant women seen in Chonnam University Hospital in KwangJu.
In this study, the blood concentrations of 6-ketoprostaglandin F1¥á and throm¡þboxane B 2were measured by radioimmunoassay.
1. The mean maternal blood concentration of 6-ketoprostglandin F1¥á in pregnancy¡þ induced hypertension group was 444¡¾42pg /ml, which was not significantly dif¡þferent from the concentration of normotensive group(452¡¾54pg /ml ).
2. The mean maternal blood concentration of thromboxane B2 in pregnancy ¡þinduced hypertension group was 560¡¾40pg /ml, which was significantly higher than the concentration of normotensive group(345¡¾31pg/ml)(P<0.05). But there was no difference between mild group and severe group.
3. There was no significant difference in thromboxane B2 to 6-keto prostaglandin F1 ratio between pregnancy-induced hypertension group(1.91¡¾0.22) and normo¡þtensive group(1.14¡¾0.26).
The ratio also was not different between mild and severe pregnancy-induced hypertension.
These result suggest that the changes in the serum levels of prostaglandins are not the cause but the result of pregnancy-induced hypertension.
KEYWORD
FullTexts / Linksout information
Listed journal information